Clal Insurance Enterprises Holdings LTD has filed its 13F form on February 06, 2025 for Q4 2024 where it was disclosed a total value porftolio of $11.1 Billion distributed in 191 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $1.07B, Invesco Exchange Traded Fd Tr with a value of $945M, Teva Pharmaceutical Industries LTD with a value of $860M, Vanguard Index Fds S&P 500 ETF with a value of $746M, and Financial Sector Spdr with a value of $584M.

Examining the 13F form we can see an decrease of $200M in the current position value, from $11.3B to 11.1B.

Clal Insurance Enterprises Holdings LTD is based out at Tel Aviv, L3

Below you can find more details about Clal Insurance Enterprises Holdings LTD portfolio as well as his latest detailed transactions.

Portfolio value $11.1 Billion
ETFs: $5.28 Billion
Technology: $2.42 Billion
Healthcare: $991 Million
Communication Services: $653 Million
Industrials: $425 Million
Consumer Cyclical: $372 Million
Utilities: $270 Million
Basic Materials: $202 Million
Other: $255 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 191
  • Current Value $11.1 Billion
  • Prior Value $11.3 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 06, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 91 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 36 stocks
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.